Search Results 811-820 of 9701 for Sulfasalazine

  1. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

    The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...

  2. Nonalcoholic Steatohepatitis Clinical Trials - Mayo Clinic Research

    This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement in liver ...

  3. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. About this study. Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public ...

  4. Somatic Mutation in Rheumatoid Arthritis - Clinical Trials

    About this study. The purpose of the study is to determine whether somatic mutations in T cells contribute to the pathogenesis of rheumatoid arthritis (RA).

  5. Gastroenterology and Hepatology - Clinical trials

    Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

  6. Vasculitis - Doctors and departments - Mayo Clinic

    This swelling and irritation of the blood vessels may thicken and weaken blood vessel walls. It can restrict blood flow and damage organs.

  7. Fibrinogen (intravenous route) - Side effects & uses - Mayo Clinic

    Fibrinogen injection is used as a supplement in bleeding patients with acquired fibrinogen deficiency. It is also used to treat acute bleeding episodes in ...

  8. Soft Tissue Sarcoma Clinical Trials - Mayo Clinic Research

    This allows immune cells to recognize and attack tumor cells. The drug could shrink cancer but could also have side effects. Researchers want to study if the ...

  9. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  10. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the signaling molecules needed for cell growth. Monoclonal antibodies, such as ...